Virtus ETF Advisers’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,635	Closed	-$45K	–	497
2024 Q4	$45K	Buy	11,635 +2,127	+22%	+$8.23K	0.02%	461
2024 Q3	$62.3K	Buy	9,508 +166	+2%	+$1.09K	0.03%	437
2024 Q2	$67.7K	Buy	+9,342	New	+$67.7K	0.03%	437